FDA Approves Momelotinib for Myelofibrosis With Anemia
The US Food and Drug Administration (FDA) today approved the JAK inhibitor momelotinib (Ojjaara) for myelofibrosis patients with anemia, according ...
© Pharma News Hubb All rights reserved.
Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy and Terms & Conditions.